About:
Jubilant Ingrevia was Demerged from Jubilant Lifesciences in February 2021. It is in the business of Speciality chemicals, Animal & human nutrition, life science chemicals, ethanol etc.
- Stock is in a continuous uptrend.
- Price today crossed the previous swing high after forming a base at Support Level (which was earlier a resistance)
- Price broke out with good volumes with good accumulation activity at the end of July.
- Spread chart also gave a breakout of the previous swing high.
Financial Results:
- Jubilant's QoQ Sales growth is 67%
- QoQ Profit growth is 211%
Jubilant Ingrevia is looking financially & technically sound. It looks good for positional investment.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在
使用條款閱讀更多資訊。